Trial Profile
Phase II study of the efficacy and tolerability of lenvatinib monotherapy in patients with sarcoma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2009
Price :
$35
*
At a glance
- Drugs Lenvatinib (Primary)
- Indications Sarcoma
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 28 Nov 2009 New trial record.